Your browser does not support JavaScript!

Santé humaine biotechnologies domaine d'application

505 entreprises et organismes intervenants dans le domaine 'Santé humaine', classés par activité.

Rejoignez la communauté
PFIZER
est cité dans une actualité de FierceBiotech
Hier à 19:48

Pfizer oncology executive hops over to Aduro as its new chief medical officer

Il y a 3 jours
Aduro Biotech has a new chief medical officer: Dimitry Nuyten, M.D., Ph.D., who joins as the company is refocusing on cancer drugs targeting the STING and APRIL pathways....
www.fiercebiotech.com
PFIZER
est cité dans une actualité de FierceBiotech
Hier à 15:43

Pfizer oncology executive hops over to Aduro as its new chief medical officer

Il y a 3 jours
Aduro Biotech has a new chief medical officer: Dimitry Nuyten, M.D., Ph.D., who joins as the company is refocusing on cancer drugs targeting the STING and APRIL pathways....
www.fiercebiotech.com
LILLY FRANCE
est cité dans une actualité de FierceBiotech
Hier à 07:36

Lilly taps Avidity's antibody-oligonucleotide conjugate tech in $35M deal

Il y a 3 jours
Eli Lilly is looking to create new drugs by combining antibodies and oligonucleotides, handing over $20 million upfront and $15 million in equity to Avidity Biosciences to use its technology to zero...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Il y a 1 semaine

EuroBiotech Report—Bayer boosts U.S. research workforce, Poxel sees diabetes success and Kymab turns to Merck KGaA for next CEO

Il y a 1 semaine
In this week's EuroBiotech Report, Bayer is planting seeds in Kendall Square, Poxel saw its shares jump, Kymab turns to former German Merck executive, J&J Vision and Edwards spend millions on...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Il y a 2 semaines

Roivant-backed Merck Serono spinout hits phase 3 diabetes goal; NDA on the horizon

Il y a 2 semaines
Poxel, a biotech spun out of Germany’s Merck and based in France, and Japanese partner Sumitomo Dainippon Pharma have announced positive data from their late-stage diabetes study in Japan. The pair...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Il y a 2 semaines

U.K. biotech Kymab nabs new CEO from Merck KGaA

Il y a 2 semaines
Kymab has hired on a new CEO, Simon Sturge, to usher the antibody specialist into its next phase of growth. Sturge joins from Merck KGaA, where he oversaw the launches of cancer drug Bavencio and...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Il y a 3 semaines

Dyne starts life with $50M, big biopharma names for muscle disease work

Il y a 3 semaines
A new Atlas Venture-incubated startup looking to treat patients with rare forms of muscle diseases has got off a $50 million series A with executives out of Amgen, Editas, Merck and Sarepta at the...
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Il y a 3 semaines

Sangamo shares jump on Pfizer, Sanofi (and its own) gene, cell therapy updates

Il y a 3 semaines
Sangamo saw its stock on the up this morning after the company posted updates to a series of its trials using a new form of gene editing and cell therapies....
www.fiercebiotech.com
2 entreprises
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Il y a 3 semaines

As Merck Research Laboratories moves into new facility, 20 staffers get the ax

Il y a 3 semaines
Merck is set to cut 20 staffers from its Research Laboratories unit as it preps to enter its new digs in South San Francisco....
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de L'Usine Nouvelle
Il y a 3 semaines

Merck booste la production et le conditionnement à Semoy (Loiret)

Il y a 3 semaines
Via un investissement de 30 millions d’euros, le laboratoire allemand Merck a posé la première pierre d’un bâtiment de conditionnement et a... - L'Usine Santé
www.usinenouvelle.com
Charger plus d'actualités